Transition from Crime to Care in Oncology: A Critical Review of Current Cancer Research and Its Applications (2022) by Mohammad A Nezami M D EPUB

Description

Cancer is widely regarded as the most challenging disease of our time. Conventional treatments and therapies generally address its symptoms, not the causes, which is why they largely prove ineffective. In his thought-provoking work, Transition from Crime to Care in Oncology, Dr. Mohammad A. Nezami-who has over a quarter of a century of experience conducting cutting-edge research treating this pernicious disease-shares his critical view on the current standard of care and colluded oncology research. He presents an eye-opening new understanding of cancer stem cell biology in concert with his “least toxic and most effective” approach to treatment. Dr. Nezami collaborates with major academic institutions and regulatory agencies while serving as a strong advocate of patients’ rights of choice when it comes to treatment of terminal disease.Insightful and revelatory, Dr. Nezami’s groundbreaking work signals an enlightening and exciting new direction for the field of oncology.

Reviews

Editorial Reviews: Review Cancer is ubiquitous in every society affecting every family in every country. Tremendous strides have been made in our understanding of the treatment of cancer. New mechanisms of treatments have been approved with immunology, vaccines, targeted therapies being developed. This has led to an increase in survival and quality of life. Despite this, we still have big gaps in our understanding and little improvements in cancer treatment for some cancers. Dr Nezami presents his understanding and new interpretation of the current state of cancer treatment and its shortfalls. This book will validate some people’s opinions and be controversial to other people. Until we can cure and control all cancers, there is room for improvement and new treatments. -Steven Hager, D.O., Medical oncologist and director of research at cCare (California Cancer Associates for Research and Excellence) About the Author Mohammad A. Nezami, MD, a world-renowned authority on integrative oncology and epigenetic sciences, is a graduate of University of Southern California and University of California San Francisco residencies. He serves as the president of Medical Centers of Hope in California. He has contributed to numerous medical publications and has made presentations to such organizations as the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). Dr. Nezami, who currently teaches and consults other physicians and oncologists, is extensively involved in research and pursuing several clinical trials in integrative oncology and epigenetic sciences.

Cancer Research